Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder

被引:0
作者
Virginia L Stauffer
Jennifer L Sniadecki
Kevin W Piezer
Jennifer Gatz
Sara Kollack-Walker
Vicki Poole Hoffmann
Robert Conley
Todd Durell
机构
[1] Lilly USA,
[2] LLC,undefined
[3] Lilly Corporate Center,undefined
来源
BMC Psychiatry | / 10卷
关键词
Schizophrenia; Olanzapine; Tardive Dyskinesia; Black Patient; White Patient;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 248 条
  • [1] Boydell J(2001)Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with the environment BMJ 323 1336-1338
  • [2] van Os J(2001)Risks for individuals with schizophrenia who are living in the community Psychiatr Serv 52 1358-1366
  • [3] McKenzie K(1996)Racial differences in the diagnosis of psychosis Schizophr Res 21 117-124
  • [4] Allardyce J(1984)Overview: American blacks and psychiatry Transcultural Psychiatry Research Review 21 83-111
  • [5] Goel R(2004)Variations in the use of second-generation antipsychotics mediation by race among adult psychiatric patients Psychiatr Serv 55 677-684
  • [6] McCreadie RG(2006)Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia Psychiatr Serv 57 133-136
  • [7] Murray RM(2004)Sex, ethnicity, and antipsychotic medication use in patients with psychosis Schizophr Res 66 169-175
  • [8] Brekke S(2003)Examination of treatment patterns by race Ment Health Serv Res 5 241-250
  • [9] John C(2002)Racial disparities in antipsychotic prescription patterns for patients with schizophrenia Amer J Psychiatry 159 567-572
  • [10] Prindle SW(2005)The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia Ment Health Serv Res 7 123-134